Pericoital Oral Contraception With Levonorgestrel

Phase 3 Completed 72 enrolled FHI 360

NaSingle-groupOpen-labelPrevention

Summary

A prospective, open-label, single arm, multicenter study to evaluate efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel

Timeline

Start: 2010-01
Primary completion: 2010-11
Completion: 2010-11

Publications

Taylor DJ, Lendvay A, Halpern V, Bahamondes LG, Fine PM, Ginde SY, Wheeless A, Raymond EG. A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel. Contraception. 2014 Mar;89(3):215-21. doi: 10.1016/j.contraception.2013.11.013. Epub 2013 Nov 26.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Levonorgestrel	Small molecule	0.75 mg	Oral

Indications

No indication recorded.